Vaccine Design and Testing – Multimedia

This eBook highlights innovative purification tools that support scientists in the production of high-quality mRNA for therapeutic applications.

In this interview, Dr. Katalin Karikó talks about discovering she had won the Nobel Prize for discoveries that accelerated the introduction of vaccines for COVID-19. She recalls her journey and some of the setbacks on the path to the mRNA vaccines.

The pandemic has ushered in a vaccines “golden era”. Long-term investment in vaccine manufacturing has been prioritized, as has the pursuit of novel vaccine platforms. In this infographic, we explore recent advances in vaccine research and development.

This eBook highlights ways that you can level up your vaccine research with selected bioreactor tools to fit your vaccine development workflow.

Increased demand has led to an overwhelming volume of LC-MS/MS data and a requirement for analytical software that can simplify its interpretation. This poster highlights a new, comprehensive software solution capable of eliminating the otherwise overwhelming efforts of manual data interpretation.

Vaccines are critical for the prevention of infectious diseases and improvement of global health. Better understanding of the immune system and the availability of advanced structural biology tools and genetic delivery systems have unlocked new possibilities to improve vaccine development.

Speaking at the Vaccine Research & Development 2022 online symposium, Zoltan Kis from the University of Sheffield discussed digital design for RNA vaccine and therapeutic production.

Speaking at the Vaccine Research & Development 2022 online symposium, Nikolai Petrovsky, Professor of Medicine at FLinder's University, delivered his talk on the first Australian-developed vaccine in over 40 years.

Download this eBook to learn more about what’s next for mRNA vaccines,
scaling up in vitro transcription for mRNA production, tools for mRNA analysis
plus the future of mRNA technology.

Messenger RNA (mRNA) therapy enables the body to make the proteins needed to prevent, treat or cure diseases but, unlike traditional biologics, mRNAs are large and delicate molecules that need to be protected by lipid nanoparticles (LNPs) on the journey to reach target cells.